All News #Library
Others
Hemispherian Initiates Phase 1/2a Trial of GLIX1 in Glioblastoma
07 Apr 2026 //
BUSINESSWIRE
Hemispherian raises tranche of a Series A to fund novel cancer therapeutics
24 Nov 2022 //
PRNEWSWIRE

Market Place
Sourcing Support